1-8 of 8
Michael Vredenburg, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Consistent Efficacy Demonstrated By Avatrombopag in Immune Thrombocytopenia (ITP) Regardless of the Number of Lines of Prior ITP Treatment

Morey Blinder, MD, Michael Vredenburg, PhD, Wei Tian, PhD, Brian Jamieson, MDBA, Keith R McCrae, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-136585
Published: 2020
Journal Articles

Characterization of Thromboembolic Events Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Caroline I. Piatek, MD, Brian Jamieson, MDBA, Michael Vredenburg, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-141273
Published: 2020
Journal Articles

Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical Study

Shivi Jain, MDMBBS, Matthew Wojdyla, PharmD, Michael Vredenburg, PhD, Brian Jamieson, MDBA, Terry B. Gernsheimer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-142764
Published: 2020
Journal Articles

Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag

Michael D Tarantino, MD, Michael Vredenburg, PhD, Wei Tian, PhD, Brian Jamieson, MDBA, Kashyap B Patel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-142788
Published: 2020
Journal Articles

Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

Lee F. Allen, MD PhD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Christine Barnett, PhD, Deirdre Mladsi, BA, Ray Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3454.
https://doi.org/10.1182/blood-2019-131822
Published: 2019
Journal Articles

Long-Term Response Rates in Patients with Chronic Immune Thrombocytopenia Treated with Avatrombopag: Additional Analyses from a Phase 3 Study and Its Extension Phase

Hanny Al-Samkari, MD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Wei Tian, PhD, Lee F. Allen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2356.
https://doi.org/10.1182/blood-2019-131215
Published: 2019
Journal Articles

The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey

James B. Bussel, MD, Alexandra Kruse, Caroline Kruse, Jody Shy, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Keith R McCrae, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1076.
https://doi.org/10.1182/blood-2019-131351
Published: 2019
Journal Articles

Platelet Response to Avatrombopag in Patients with Chronic Immune Thrombocytopenia: Additional Analyses from a Phase 3 Study and Its Extension

Srikanth Nagalla, MBBS,MS, Michael Vredenburg, PhD, Wei Tian, PhD, Lee F. Allen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1071.
https://doi.org/10.1182/blood-2019-130963
Published: 2019